By Michael Gwarisa In a landmark move that could transform the global fight against HIV, the World Health Organization (WHO) today issued new guidelines endorsing the use of injectable lenacapavir (LEN) administered twice a year as an additional pre-exposure prophylaxis (PrEP) option. The announcement was made at the 13th International AIDS Society Conference (IAS 2025) on HIV Science, currently underway in Kigali, Rwanda. LEN is the first long-acting injectable PrEP designed to protect people at risk of HIV with just two doses annually, offering a highly effective alternative to daily…
Read MoreWHO Recommends Twice-Yearly Injectable Lenacapavir as Game-Changer in HIV Prevention
